Jun 25, 2026 04:01PM
Jun 25, 2026 04:01PM
Jun 23, 2026 04:00AM
Jun 23, 2026 04:00AM
Jun 22, 2026 07:01AM
Jun 22, 2026 07:00AM
May 7, 2026 07:00AM Ligand Reports First Quarter 2026 Financial Results
Apr 28, 2026 05:06AM
Apr 27, 2026 02:55PM
Apr 27, 2026 01:56PM
Apr 27, 2026 07:01AM
Apr 27, 2026 07:00AM
Apr 27, 2026 07:00AM
Apr 27, 2026 07:00AM Ligand to Acquire XOMA Royalty, Further Accelerating Profit Growth and Strengthening Ligand’s Position as a Leading Biopharma Royalty Aggregator
Feb 26, 2026 07:00AM
Dec 9, 2025 04:23PM
Nov 7, 2025 08:01AM
Nov 6, 2025 07:00AM
Aug 7, 2025 02:35PM
Aug 7, 2025 07:00AM
Jul 30, 2025 06:32AM Ligand Pharma (LGND) PT Raised to $162 at Oppenheimer
Jul 17, 2025 07:34AM
Jul 10, 2025 08:02AM
Jul 10, 2025 08:00AM
Jul 2, 2025 07:01AM
Jul 2, 2025 07:00AM
Jul 2, 2025 07:00AM
May 8, 2025 07:00AM Ligand Reports First Quarter 2025 Financial Results
Apr 17, 2025 06:00AM
Feb 27, 2025 07:00AM
Dec 10, 2024 09:15AM
Dec 10, 2024 09:00AM
Nov 7, 2024 07:00AM
Oct 17, 2024 07:30AM
Aug 6, 2024 04:01PM Ligand Reports Second Quarter 2024 Financial Results
Jul 24, 2024 06:33AM
Jul 24, 2024 06:30AM
Jul 8, 2024 07:03AM
Jul 8, 2024 07:00AM
May 7, 2024 04:00PM
Feb 27, 2024 07:00AM
Dec 12, 2023 12:01PM Ligand Pharma (LGND) Provides Update on Portfolio Progress and Recent Transactions; Introduces 2024 Guidance
Dec 12, 2023 12:01PM
Dec 6, 2023 04:02PM
Dec 1, 2023 08:21AM
Dec 1, 2023 08:20AM
Nov 8, 2023 04:01PM
Nov 1, 2023 08:01AM
Nov 1, 2023 08:00AM Ligand Acquires Royalty on Sanofi’s TZIELD® for $20 Million
Sep 27, 2023 09:02AM

1,164,407 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All